Search

everythinglearnresearchcommunity

for

Search:↓

FFA's causes may include environmental triggers and genetic factors.

Frontal fibrosing alopecia often occurs after menopause, with delayed diagnosis and possible links to certain medications and conditions.

Forsythiaside A helps protect cells and liver from damage by reducing oxidative stress and boosting antioxidants.

The article concludes that understanding Frontal Fibrosing Alopecia (FFA) is crucial for effective treatment, which includes medication like 5α-reductase inhibitors and hydroxychloroquine.

Frontal fibrosing alopecia mostly affects postmenopausal women, with diagnosis often delayed by 3 years.

Fisetin may help treat psoriasis and reduce skin inflammation.

The flexible fixed-sequence testing method allows for more effective evaluation of multiple goals in a clinical trial while controlling the risk of false positives.

Dermatologists should carefully choose treatments for FFA to avoid worsening the condition.

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting older women, with no known cause and treatments that may help stabilize hair loss.

A 46-year-old man was diagnosed with frontal fibrosing alopecia, a condition usually seen in postmenopausal women.

Frontal Fibrosing Alopecia involves disrupted cholesterol pathways, fibrosis, and increased mast cells.

Frontal fibrosing alopecia in families shows similar signs to individual cases and may have a genetic link.

Frontal fibrosing alopecia can sometimes look like syphilitic hair loss.

The Protein-Sparing Modified Fast is effective for rapid weight loss and maintaining it, but requires medical supervision and can have side effects.

Frontal Fibrosing Alopecia is a type of hair loss affecting mostly older women, with no agreed best treatment.

Hair follicle sampling is a feasible method to measure FMRP and FMR1 mRNA levels in children.

Very-long-chain acyl-CoA synthetases and fatty acid transport proteins play key roles in fatty acid metabolism and lipid processing in different tissues.

The pseudo 'fringe sign' can also appear in frontal fibrosing alopecia, not just in traction alopecia, showing that this condition may be more common than thought.

Some postmenopausal women with frontal fibrosing alopecia stopped losing hair with finasteride treatment, hinting at a possible hormonal cause.

Forsythiaside A helps reduce brain damage from lack of blood flow by activating certain protective pathways.

The method greatly improves low-light sports images' quality and reduces artifacts.

The flaky skin mouse mutation is a natural model for studying human psoriasis.

Fetuin-A levels are higher in PCOS patients, suggesting it may play a role in the condition.

Hair follicle sampling is a practical method for measuring biomarkers in children with and without Fragile X syndrome.

Early diagnosis and quick treatment improve life quality for FFA patients.

Frontal Fibrosing Alopecia is a hair loss condition mainly affecting postmenopausal women, with unclear causes and various clinical patterns.

The model improves understanding of androgen interactions by focusing on signal intensity and system capacity.

FFA is more common in postmenopausal women, can affect younger women, and may stabilize over time.

Frontal Fibrosing Alopecia is a slowly progressing hair loss condition, likely underdiagnosed, with ineffective treatments, needing more research to understand it fully.